BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 170219)

  • 1. Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. I. Genetics of resistance in AKR mice.
    Colombatti A; Collavo D; Biasi G; Chieco-Bianchi L
    Int J Cancer; 1975 Sep; 16(3):427-34. PubMed ID: 170219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. II. A dominant epistatic susceptibility gene.
    Colombatti A; Collavo D; Biasi G; Chieco-Bianchi L
    Int J Cancer; 1975 Sep; 16(3):435-41. PubMed ID: 170220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo interactions between murine leukemia and sarcoma viruses.
    Chieco-Bianchi L; Collavo D; Colombatti A; Biasi G
    Bibl Haematol; 1975; (40):613-20. PubMed ID: 169829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of murine sarcoma virus (MSV)--induced tumors in AKR mice: Evidence that late progressing and early regressing tumors are controlled by different gents.
    Colombatti A; Chieco-Bianchi L; De Rossi A; D'Andrea E; Collavo D
    Int J Cancer; 1977 Apr; 19(4):565-75. PubMed ID: 66212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. III. Possible correlation with endogenous virus production.
    Colombatti A; Collavo D; Biasi G; Chieco-Bianchi L
    Bibl Haematol; 1975 Oct; (43):448-50. PubMed ID: 183715
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between Moloney MSV tumor resistance and endogenous virogene expression in AKR mouse strain and its hybrids.
    Colombatti A; De Rossi A; Taylor BA; Chieco-Bianchi L; Meier H
    Int J Cancer; 1978 Feb; 21(2):179-85. PubMed ID: 203548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice.
    Rowe WP
    J Exp Med; 1972 Nov; 136(5):1272-85. PubMed ID: 4343244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains.
    Hilgers J; Galesloot J
    Int J Cancer; 1973 May; 11(3):780-93. PubMed ID: 4364724
    [No Abstract]   [Full Text] [Related]  

  • 15. Genes affecting mink cell focus-inducing (MCF) murine leukemia virus infection and spontaneous lymphoma in AKR F1 hybrids.
    Rowe WP; Hartley JW
    J Exp Med; 1983 Aug; 158(2):353-64. PubMed ID: 6224881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus.
    Frankel AE; Fischinger PJ
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3705-9. PubMed ID: 185623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
    Mayer AM; Basombrio MA; Pasqualini CD
    Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice.
    Rowe WP; Hartley JW
    J Exp Med; 1972 Nov; 136(5):1286-301. PubMed ID: 4343245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N; Boone CW; Holden HT; Herberman RB
    Int J Cancer; 1978 Jan; 21(1):78-84. PubMed ID: 203543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.